Implication of intestinal VDR deficiency in inflammatory bowel disease

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 1, 2013, Pages 2118-2128

  Kim, Jung Hwan ^a   Yamaori, Satoshi ^a   Tanabe, Tomotaka ^a   Johnson, Caroline H ^a   Krausz, Kristopher W ^a   Kato, Shigeaki ^b   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bile acid; Inflammatory bowel disease (IBD); Vitamin D receptor (VDR)

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CHOLIC ACID; COLLAGEN; DEXTRAN SULFATE; TAURINE; TAUROCHOLIC ACID; VITAMIN D RECEPTOR;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY SIZE; CALCIUM GENE; CLINICAL EXAMINATION; COLITIS; COLLAGEN GENE; COLON MUCOSA; EXPERIMENTAL MODEL; FECES ANALYSIS; FECES COLOR; GENE; GENE DISRUPTION; GENE EXPRESSION; HISTOPATHOLOGY; INTESTINAL PROLIFERATION RELATED GENE; INTESTINE INJURY; INTESTINE MUSCLE; METABOLOMICS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; VDR GENE;

ANIMALS; BIOLOGICAL MARKERS; DEXTRAN SULFATE; GENE EXPRESSION REGULATION; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MICE; MICE, MUTANT STRAINS; RECEPTORS, CALCITRIOL;

MUS;

EID: 84867894831     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.09.020     Document Type: Article

References (43)

1. D.K. Podolsky Inflammatory bowel disease N. Engl. J. Med. 347 2002 417 429
2. E.V. Loftus Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences Gastroenterology 126 2004 1504 1517
3. S. Schreiber, and J. Hampe Genomics and inflammatory bowel disease Curr. Opin. Gastroenterol. 16 2000 297 305
4. A.D. Levine, and C. Fiocchi Immunology of inflammatory bowel disease Curr. Opin. Gastroenterol. 16 2000 306 309
5. R.J. Xavier, and D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 2007 427 434
6. R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H.F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and human health: lessons from vitamin D receptor null mice Endocr. Rev. 29 2008 726 776
7. S.V. Ramagopalan, A. Heger, A.J. Berlanga, N.J. Maugeri, M.R. Lincoln, A. Burrell, L. Handunnetthi, A.E. Handel, G. Disanto, S.M. Orton, C.T. Watson, J.M. Morahan, G. Giovannoni, C.P. Ponting, G.C. Ebers, and J.C. Knight A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution Genome Res. 20 2010 1352 1360
8. M. Froicu, V. Weaver, T.A. Wynn, M.A. McDowell, J.E. Welsh, and M.T. Cantorna A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases Mol. Endocrinol. 17 2003 2386 2392
9. J. Kong, Z. Zhang, M.W. Musch, G. Ning, J. Sun, J. Hart, M. Bissonnette, and Y.C. Li Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier Am. J. Physiol. Gastrointest. Liver Physiol. 294 2008 G208 G216
10. M. Froicu, and M.T. Cantorna Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury BMC Immunol. 8 2007 5
11. M.A. Schepens, A.J. Schonewille, C. Vink, E.M. van Schothorst, E. Kramer, T. Hendriks, R.J. Brummer, J. Keijer, R. van der Meer, and I.M. Bovee-Oudenhoven Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats J. Nutr. 139 2009 1525 1533
12. M. Kumari, N.B. Khazai, T.R. Ziegler, M.S. Nanes, S.A. Abrams, and V. Tangpricha Vitamin D-mediated calcium absorption in patients with clinically stable Crohn's disease: a pilot study Mol. Nutr. Food Res. 54 2010 1085 1091
13. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 1990 694 702
14. J.K. Nicholson, J.C. Lindon, and E. Holmes 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 29 1999 1181 1189
15. J.L. Griffin The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? Philos. Trans. R. Soc. B-Biol. Sci. 361 2006 147 161
16. J.T. Brindle, H. Antti, E. Holmes, G. Tranter, J.K. Nicholson, H.W. Bethell, S. Clarke, P.M. Schofield, E. McKilligin, D.E. Mosedale, and D.J. Grainger Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics Nat. Med. 8 2002 1439 1444
17. Y. Sato, I. Suzuki, T. Nakamura, F. Bernier, K. Aoshima, and Y. Oda Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology J. Lipid Res. 53 2012 567 576
18. C. Chen, Y.M. Shah, K. Morimura, K.W. Krausz, M. Miyazaki, T.A. Richardson, E.T. Morgan, J.M. Ntambi, J.R. Idle, and F.J. Gonzalez Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis Cell Metab. 7 2008 135 147
19. M.E. Dumas, R.H. Barton, A. Toye, O. Cloarec, C. Blancher, A. Rothwell, J. Fearnside, R. Tatoud, V. Blanc, J.C. Lindon, S.C. Mitchell, E. Holmes, M.I. McCarthy, J. Scott, D. Gauguier, and J.K. Nicholson Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice Proc. Natl. Acad. Sci. U. S. A. 103 2006 12511 12516
20. G.L. Jones, E. Sang, C. Goddard, R.J. Mortishire-Smith, B.C. Sweatman, J.N. Haselden, K. Davies, A.A. Grace, K. Clarke, and J.L. Griffin A functional analysis of mouse models of cardiac disease through metabolic profiling J. Biol. Chem. 280 2005 7530 7539
21. B.B. Madison, L. Dunbar, X.T. Qiao, K. Braunstein, E. Braunstein, and D.L. Gumucio Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine J. Biol. Chem. 277 2002 33275 33283
22. G.P. Hayhurst, Y.H. Lee, G. Lambert, J.M. Ward, and F.J. Gonzalez Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis Mol. Cell. Biol. 21 2001 1393 1403
23. C.P. Granvil, A.M. Yu, G. Elizondo, T.E. Akiyama, C. Cheung, L. Feigenbaum, K.W. Krausz, and F.J. Gonzalez Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam Drug Metab. Dispos. 31 2003 548 558
24. C. Moolenbeek, and E.J. Ruitenberg The Swiss roll: a simple technique for histological studies of the rodent intestine Lab. Anim. 15 1981 57 59
25. V. Costarelli, T.J. Key, P.N. Appleby, D.S. Allen, I.S. Fentiman, and T.A. Sanders A prospective study of serum bile acid concentrations and colorectal cancer risk in post-menopausal women on the island of Guernsey Br. J. Cancer 86 2002 1741 1744
26. A.R. Baker, D.P. McDonnell, M. Hughes, T.M. Crisp, D.J. Mangelsdorf, M.R. Haussler, J.W. Pike, J. Shine, and B.W. O'Malley Cloning and expression of full-length cDNA encoding human vitamin D receptor Proc. Natl. Acad. Sci. U. S. A. 85 1988 3294 3298
27. Y. Kamei, T. Kawada, T. Fukuwatari, T. Ono, S. Kato, and E. Sugimoto Cloning and sequencing of the gene encoding the mouse vitamin D receptor Gene 152 1995 281 282
28. R.B. Sartor Microbial influences in inflammatory bowel diseases Gastroenterology 134 2008 577 594
29. E. Cario Toll-like receptors in inflammatory bowel diseases: a decade later Inflamm. Bowel Dis. 16 2010 1583 1597
30. E. Cario, and D.K. Podolsky Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease Infect. Immun. 68 2000 7010 7017
31. S. Akira, S. Uematsu, and O. Takeuchi Pathogen recognition and innate immunity Cell 124 2006 783 801
32. J.K. Yamamoto-Furusho, and D.K. Podolsky Innate immunity in inflammatory bowel disease World J. Gastroenterol. 13 2007 5577 5580
33. M. Gersemann, S. Becker, I. Kubler, M. Koslowski, G. Wang, K.R. Herrlinger, J. Griger, P. Fritz, K. Fellermann, M. Schwab, J. Wehkamp, and E.F. Stange Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis Differentiation 77 2009 84 94
34. X. Zheng, K. Tsuchiya, R. Okamoto, M. Iwasaki, Y. Kano, N. Sakamoto, T. Nakamura, and M. Watanabe Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis Inflamm. Bowel Dis. 17 2011 2251 2260
35. T. Bouckenooghe, C. Remacle, and B. Reusens Is taurine a functional nutrient? Curr. Opin. Clin. Nutr. Metab. Care 9 2006 728 733
36. M. Son, J.I. Ko, W.B. Kim, H.K. Kang, and B.K. Kim Taurine can ameliorate inflammatory bowel disease in rats Adv. Exp. Med. Biol. 442 1998 291 298
37. G. Schuller-Levis, M.R. Quinn, C. Wright, and E. Park Taurine protects against oxidant-induced lung injury: possible mechanism(s) of action Adv. Exp. Med. Biol. 359 1994 31 39
38. M.W. Son, J.I. Ko, H.M. Doh, W.B. Kim, T.S. Park, M.J. Shim, and B.K. Kim Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats Arch. Pharm. Res. 21 1998 531 536
39. T. Yamada, and M.B. Grisham Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation Klin. Wochenschr. 69 1991 988 994
40. S.T. Test, M.B. Lampert, P.J. Ossanna, J.G. Thoene, and S.J. Weiss Generation of nitrogen-chlorine oxidants by human phagocytes J. Clin. Invest. 74 1984 1341 1349
41. D. Delic, U. Warskulat, E. Borsch, S. Al-Qahtani, S. Al-Quraishi, D. Haussinger, and F. Wunderlich Loss of ability to self-heal malaria upon taurine transporter deletion Infect. Immun. 78 2010 1642 1649
42. R.M. Gadaleta, B. Oldenburg, E.C. Willemsen, M. Spit, S. Murzilli, L. Salvatore, L.W. Klomp, P.D. Siersema, K.J. van Erpecum, and S.W. van Mil Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-kappaB signaling in the intestine Biochim. Biophys. Acta 1812 2011 851 858
43. R.M. Gadaleta, K.J. van Erpecum, B. Oldenburg, E.C. Willemsen, W. Renooij, S. Murzilli, L.W. Klomp, P.D. Siersema, M.E. Schipper, S. Danese, G. Penna, G. Laverny, L. Adorini, A. Moschetta, and S.W. van Mil Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease Gut 60 2011 463 472